Agonist-induced internalization of G protein-coupled receptors plays an important role in signal regulation. The underlying mechanisms of the internalization of the human neuropeptide Y 2 receptor (hY 2 R), as well as its desensitization, endocytosis, and resensitization are mainly unknown. In the present study we have investigated the role of carboxyl-terminal (C-terminal) Ser/Thr residues and acidic amino acids in regulating receptor internalization, arrestin interaction, and recycling by fluorescence microscopy, cell surface enzymelinked immunosorbent assay, and bioluminescence resonance energy transfer in several cell lines. Strikingly, C-terminal truncation mutants revealed two different internalization motifs. Whereas a distal motif 373 DSXTEXT 379 was found to be the primary regulatory internalization sequence acting in concert with arrestin-3, the proximal motif 347 DXXXSEX-SXT 356 promoted ligand-induced internalization in an arrestin-3-independent manner. Moreover, we identified a regulatory sequence located between these internalization motifs ( 357 FKAKKNLEVRKN 368 ), which serves as an inhibitory element. We found that hY 2 R recycling is also governed by structural determinants within the proximal internalization motif. In conclusion, these results indicate that the hY 2 R C terminus is involved in multiple molecular events that regulate internalization, interaction with arrestin-3, and receptor resensitization. Our findings provide novel insights into complex mechanisms of controlled internalization of hY 2 R, which is likely applicable to other GPCRs.
G protein-coupled receptors (GPCRs) 2 constitute the largest family of cell-surface receptors with ϳ800 known human subtypes. Members of this family share a common architecture of seven membrane-spanning ␣-helices connected by extra-and intracellular loops. GPCRs can be activated by a wide variety of extracellular stimuli and regulate diverse physiological processes (1) . Because they are responsible for a multitude of cellular responses and their dysfunction can result in many diseases (2) (3) (4) , this receptor family represents highly important pharmaceutical targets. More than one-third of the currently available therapeutics act on GPCRs (1) . Whereas antagonists mainly prevent receptor interactions with endogenous ligands, agonist drugs might lead to distinct effects in addition to receptor activation, e.g. functional antagonism by receptor removal from the surface (5), direct intracellular cross-signaling (6) , and may behave as biased ligands (7) . Current information about the complex intracellular network of GPCRs regulation is rather limited. Therefore, it is of great interest to unravel the mechanisms and regulation modalities of receptor internalization and subsequent resensitization processes.
The Y 2 R is one of four human neuropeptide Y (NPY) receptor subtypes (hY 1 R, hY 2 R, hY 4 R, and hY 5 R) and belongs to the rhodopsin-like superfamily (class A) of GPCRs. YRs together with their three native ligands, NPY, pancreatic polypeptide (PP), and peptide YY (PYY), form a multiligand/ multireceptor system (8) , which is involved in many important physiological processes, such as regulation of food intake (9) , control of blood pressure, and regulation of pancreatic and gastric secretion (10) . The Y 2 R is predominantly expressed as a 381-amino acid protein in the brain cortex (11, 12) , hippocampus, intestine, and certain blood vessels (8, 13, 14) and is involved in the inhibition of neurotransmitter release (15) , regulation of memory retention (16) , circadian rhythm, and angiogenesis (13) , which makes it an attractive target for drug development. Potent Y 2 R agonists were suggested as therapy for epilepsy, because Y 2 R selective ligands have been shown to reduce epileptic seizures (17) . Y 2 R selective peptides have also been shown to reduce food intake and lead to a significant loss in body weight (18) . Because it has been reported that not only Y 1 Rs but also Y 2 Rs are expressed in distinct tumors, e.g. renal cell carcinomas, ovarian cancers, adrenal gland, and related tumors, the Y 2 R is a promising target for tumor diagnostics and therapy by using selectively labeled agonistic peptides (19, 20) . Previous findings showed that, like Y 1 R and Y 4 R, Y 2 R undergoes rapid agonist-induced internalization (21) .
In the current study we generated a series of C-terminal truncated hY 2 R mutants to investigate the impact of C-terminal sequences on receptor internalization properties. We identified novel regulatory motifs within the hY 2 R C-terminal domain, which contribute to receptor internalization and arrestin-3 (arr-3) association. Interestingly, our findings revealed arr-3-dependent and -independent hY 2 R internalization, and also led to the identification of a sequence that modulates receptor recycling.
EXPERIMENTAL PROCEDURES
Materials-Porcine NPY (pNPY) was produced by automated solid phase peptide synthesis using the Fmoc/tBu (9-fluorenylmethoxycarbonyl-tert-butyl) strategy (22) . Propionylated [ 
]pNPY) was purchased from GE Healthcare. Materials for tissue culture were supplied by PAA Laboratories GmbH (Pasching, Austria). 8-well -slides were obtained from ibidi GmbH (Martinsried, Germany), 48-well plates were from Greiner Bio-One GmbH (Frickenhausen, Germany), and white/black opaque 96-well plates were from Nunc (Rochester, NY). Coelenterazine-h was obtained from DiscoveRx (Fremont, CA). Lipofectamine TM 2000 transfection reagent and Opti-MEM I reduced serum media were purchased from Invitrogen. Metafectene TM transfection reagent was obtained from Biontex Laboratories GmbH (Martinsried/Planegg, Germany) and poly-D-lysine from Sigma. Anti-HA-peroxidase was purchased from Roche Diagnostics GmbH and TMB solution was from Calbiochem (Darmstadt, Germany).
Generation of YR Mutants and Arrestin-3 Variants-For fluorescence detection the cDNA of the hY 2 R was C-terminal fused to the cDNA of the enhanced yellow fluorescent protein (EYFP), as previously described (23, 24) . Mutations, deletions, and truncations were introduced by using QuikChange TM site-directed mutagenesis (Stratagene, La Jolla, CA). To perform enzyme-linked immunosorbent assays (ELISA) for quantification of receptor internalization rates, an N-terminal HA tag (25) was inserted downstream of the start codon of the hY 2 R. To visualize EYFP-tagged receptors in parallel with arr-3 in a fluorescence-based arrestin recruitment assay, bovine arr-3 was C-terminal fused to the red fluorescent protein Cherry (pCherry-N E/S vector was a kind gift of M. Hatzfeld; Martin-Luther University, Halle-Wittenberg). Pre-activated, phosphorylation-independent arr-3 constructs were obtained by distinct amino acid substitutions, as described elsewhere (26) . A dominant positive variant of arr-3, bearing the triple alanine substitution I386A,V387A,F388A (arr-3(3A)), was generated by using arr-3-Cherry in a QuikChange site-directed mutagenesis.
Plasmid Construction for Bioluminescence Resonance Energy Transfer (BRET)-For BRET assays bovine arr-3 was Nterminal tagged with Venus (27) (Venus plasmid was a generous gift from Dr. J. A. Javitch, Columbia University). The sequence of the wild type and mutant HA-tagged hY 2 Rs were C-terminal fused with Renilla luciferase variant 8 (Rluc8) (28) (a plasmid harboring Rluc8 was a generous gift of Dr. Nevin A. Lambert, Medical College of Georgia). For the overexpression of human G protein-coupled receptor kinase 2 (GRK2) in COS-7 cells, the GRK2 sequence was included in hY 2 R-Rluc8 (GRK2 sequence was cloned from a vector kindly provided by Dr. Antonio De Blasi, University of Rome "Sapienza," Rome, Italy) (for details, see supplemental data). All constructs were verified by DNA sequencing.
Cell Culture, Transfection, and Functional Studies-HEK293 cells (human embryonic kidney) and COS-7 cells (African green monkey) were cultured, as previously described (25) . SMS-KAN and MHH-NB-11 cells (both human neuroblastoma cells that express the hY 2 R endogenously) were grown, as described (29) . For live cell imaging HEK293 and SMS-KAN cells were plated into sterile 8-well -slides and MHH-NB-11 cells were plated in collagen-coated 8-well -slides. For cell surface ELISA studies HEK293 cells were seeded onto 48-well plates pre-treated with 0.01% (w/v) poly-D-lysine in phosphate-buffered saline (PBS). Cells were grown to 70% confluence and transfected with 1 g of plasmid DNA encoding hY 2 R mutants C-terminal fused to EYFP or cotransfected with either 0.1 g of plasmid DNA coding for bovine arr-3-Cherry or 0.2 g of phosphorylation-independent bovine arr-3(3A)-Cherry using Lipofectamine TM 2000 transfection reagent. For signal transduction assays (inositol phosphate accumulation in response to agonist stimulation) COS-7 cells were seeded into 24-well plates and transiently co-transfected with 0.32 g of plasmid DNA encoding for the hY 2 R mutants C-terminal fused to EYFP and 0.08 g of plasmid DNA coding for the chimeric G-protein G␣ qi4 (kindly provided by E. Kostenis) using Metafectene transfection reagent. Signal transduction assays were performed as described previously (25, 30) . Radioligand binding studies were performed using COS-7 cells, seeded into 25-cm 2 cell culture flasks and transfected with 4 g of DNA encoding for the hY 2 R wild type or mutants C-terminal fused to EYFP using Metafectene transfection reagent. Displacement radioligand binding assays were carried out with [ 3 H]pNPY (radioactive concentration: 7.4 MBq/ml; specific activity: 3.55 TBq/mmol) and increasing concentrations of pNPY as described elsewhere (31) .
BRET Assays-BRET assays (32-35) were used to characterize the binding of Venus-arr-3 to wild type hY 2 R-RLuc8 or the luciferase-fused ⌬357, ⌬369, ⌬342-356, ST1* (S351A,S354A,T356A), and ST2* (S374A,T376A,T379A) mutants. COS-7 cells were transfected with increasing amounts of Venus-arr-3 (0 -12 g) with 35-200 ng of plasmids encoding wild type and mutant hY 2 R using Lipofectamine 2000, according to the manufacturer's protocol. Twenty-four hours after transfection, cells were re-seeded into white (luminescence measurements) or black (fluorescence determination) opaque 96-well microplates. Forty-eight hours post-transfection, the medium was replaced with HEPES-buffered PBS. Eight min after agonist stimulation (10 Ϫ6 M pNPY), 5 M coelenterazine-h was added and luminescence was measured 15 min after stimulation using a POLARstar Optima dual channel luminometer and fluorimeter microplate reader (BMG Labtech, Cary, NC). Luminescence was measured through 465-485 and 522.5-547.5 nm bandpass filters. The net BRET ratio was calculated as the long wavelength emission divided by the short wavelength emission and expressed as the relative change compared with unstimulated cells. The expression of Venus-arr-3 was evaluated using fluorescence at 535 nm upon excitation by 485 nm. The Venus-arrestin fluorescence was normalized by the basal luminescence from the corresponding wild type or mutant hY 2 R-RLuc8 to account for variations in cell numbers and expression levels. The resulting curves were fit by non-linear regression to a one-site hyperbola model using Prism 5.04 (GraphPad Software, San Diego, CA). To assess the difference between the respective wild type and mutant arrestin curves, a global fit algorithm based on the extra sum-of-squares F test was used.
Quantification of Receptor Cell Surface Density and Internalization by Cell Surface ELISA-To quantify plasma-membrane receptors prior and after stimulation, a cell surface ELISA with N-terminal HA-tagged wild type or mutant receptors (36) was carried out as described previously (37) , with slight modifications. To investigate the influence of arr-3 overexpression on hY 2 R internalization, cells were co-transfected with arr-3-Cherry. Briefly, 24 h post-transfection cells were starved followed by ligand stimulation (10 Ϫ6 M pNPY) for different time periods (to determine cell surface density, cells were not stimulated). To stop the internalization process cells were fixed, blocked overnight at 4°C in Opti-MEM, and then probed with anti-HA-peroxidase conjugate (1:1000).
Quantification of the bound peroxidase was performed as described (37) .
Live Cell Imaging with Fluorescence Microscopy-Fluorescence microscopy studies were performed using a Zeiss Axio Observer microscope with an ApoTome Imaging System equipped with a Heating Insert P Lab-Tek S1 unit. Fluorescence images from living cells were taken as described previously (21) at 37°C on a heated microscope stage using the AxioVision Rel. 4.6 software. To characterize the internalization properties of hY 2 R constructs as well as to follow arr-3 translocation in living cells, cells were starved in Opti-MEM for 30 min and treated with 10 Ϫ6 M pNPY at 37°C for the indicated time periods. To study receptor recycling in living cells the ligand was removed, cells were washed several times with PBS, and receptors were allowed to recover for 30 -120 min.
RESULTS
Internalization of hY 2 R in Living Cells-To investigate agonist-dependent hY 2 R internalization in living cells, HEK293 cells that transiently express hY 2 R-EYFP were incubated with 10 Ϫ6 M pNPY for 10, 30, and 60 min. The internalization was analyzed by fluorescence microscopy. Prior to agonist stimulation hY 2 Rs are localized entirely in the cell membrane. Upon agonist stimulation the receptors are rapidly internalized and visible in vesicular compartments (Fig. 1A, upper panel) . To visu- alize the remaining receptors at the cell surface, pictures were taken by focusing exclusively on the cell membrane with a constant exposure time (Fig. 1A, lower panel) .
To exclude the possibility that the internalization properties of the hY 2 R subtype are due to the exogenous expression in the HEK293 cell system, we also investigated the internalization in two human cell lines known to express the receptor endogenously, SMS-KAN (14) and MHH-NB-11. As no suitable specific Y 2 R antibodies are available, we transiently transfected hY 2 R-EYFP for visualization. Upon agonist stimulation the receptor is internalized in a comparable mode in all tested cell lines (Fig. 1B) . Thus, hY 2 R internalization is not cell type dependent and occurs in cells that endogenously express the receptor.
To address the impact of arrestins on the internalization processes co-transfection of arr-2-Cherry or arr-3-Cherry with hY 2 R-EYFP was performed in all three cell lines and analyzed by fluorescence microscopy. Whereas arr-3-Cherry showed a clear redistribution to endocytic vesicles after stimulation with pNPY ( Fig. 1D ), we did not detect a significant recruitment of arr-2-Cherry (data not shown). Thus, hY 2 R internalization is preferentially mediated by arr-3 in all three cell lines.
To quantify the observed internalization process in HEK293 cells, we performed a modified cell surface ELISA. After stimulation of receptor internalization by exposure to 10 Ϫ6 M agonist for 10, 30, and 60 min, respectively, the percentage of the remaining cell surface receptors in cells transfected with hY 2 R-EYFP decreased with time ( Fig. 1C , white bars). Additional overexpression of arr-3 enhanced the internalization, as indicated by the reduction of remaining cell surface receptors from 78 Ϯ 2 to 62 Ϯ 2% after 10 min, from 65 Ϯ 3 to 41 Ϯ 3% after 30 min, and from 48 Ϯ 2 to 23 Ϯ 0.1% after 60 min (Fig. 1C, gray bars) .
C-terminal Truncations Reveal Different Internalization Phenotypes-To clarify the role of the C terminus for hY 2 R internalization, a series of truncation mutants were generated, which were C-terminal shortened by 13 to 40 of the total 53 residues ( Fig. 2A , for lower magnification images, see supplemental Fig. S1 ). All truncated variants are normally transported to the plasma membrane and are not significantly different when compared with wild type as indicated by fluorescence microscopy (Fig. 2B, 0Ј ) and ELISA (Table 1) . Moreover, they bind pNPY normally (wild type: IC 50 ϭ 1.2 Ϯ 0.01 nM; ⌬342: IC 50 ϭ 1.8 Ϯ 1.1 nM) and inositol phosphate accumulation assays revealed EC 50 values and efficacies (E max ) in the same range as wild type hY 2 R (Table 1) . Internalization of these mutants was studied by fluorescence microscopy (Fig. 2B) . Surprisingly, in contrast to all other deletion variants (⌬342, ⌬352, and ⌬369), only the mutant ⌬357, lacking 25 C-terminal residues, internalized only slightly slower than wild type receptor. Taking into account that ⌬369 did not internalize, whereas ⌬357 did, we generated the mutant ⌬369_5Q with five Lys and Arg residues (K358Q,K360Q,K361Q,R366Q,K367Q) simultaneously substituted to Gln to neutralize the positive charge of the 358 -369 sequence. Interestingly, in contrast to ⌬369, internalization of ⌬369_5Q was observed, albeit with a much slower rate than wild type. These data show that the distal C terminus is important for internalization, whereas the positively charged segment, 357 FKAKKNLEVRKN 368 , is an inhibitory element. Next, two mutants were generated that lack the central part of the C terminus, ⌬342-356 and ⌬342-372. Interestingly, both mutants internalized rapidly, similar to wild type. Mutant ⌬357 and ⌬342-372 have an identical sequence up to residue 341, but carry different C-terminal extensions. As both variants internalize after agonist stimulation, in contrast to ⌬342, these results suggest that the C terminus of hY 2 R contains two distinct internalization motifs, located within residues 343-356 and 373-381. In addition to microscopy studies, internalization kinetics by means of the remaining cell surface receptors of hY 2 R mutants were examined by cell surface ELISA (Fig. 2C) . Absence of internalization after 60 min stimulation was confirmed for mutants ⌬342, ⌬352, and ⌬369 (⌬342, 105 Ϯ 2%; ⌬352, 98 Ϯ 3%; ⌬369, 103 Ϯ 1). ⌬357 and ⌬369_5Q internalized, although not as rapidly as wild type (⌬357, 76 Ϯ 2%; ⌬369_5Q, 87 Ϯ 2%; wild type, 48 Ϯ 2), whereas ⌬342-356 and ⌬342-372 displayed considerably faster internalization properties compared with wild type (⌬342-356, 17 Ϯ 1%; ⌬342-372, 27 Ϯ 2%). These data are consistent with the internalization properties obtained by fluorescence microscopy (Fig. 2B) . To confirm that mutant hY 2 R internalization properties are not limited to HEK293 cells, the internalization of selected mutants (⌬357, ⌬369, ⌬369_5Q, and ⌬342-372) were studied in MHH-NB-11 and SMS-KAN cells (Fig. 3) . Internalization properties of all studied mutants are comparable with HEK293 cells, demonstrating that internalization of hY 2 R variants is not cell type dependent. Next, we tested whether both motifs can recruit arr-3 in HEK293 cells. To this end, all internalizing mutants, namely ⌬357, ⌬369_5Q, ⌬342-356, and ⌬342-372, were cotransfected with arr-3-Cherry. Prior to agonist treatment receptor-EYFP fluorescence was mainly localized in the plasma membrane and arr-3-Cherry fluorescence was homogenously distributed in the cytoplasm. Agonist stimulation led to a rapid redistribution of arr-3-Cherry from a diffuse cytoplasmic to a membrane-associated vesicular pattern only for wild type, ⌬342-356, and ⌬342-372, indicated by the orange hot spots in the membrane area (Fig. 4, right panel) . For mutants ⌬357 and ⌬369_5Q no arr-3-Cherry translocation was detected, as indicated by the sustained diffuse distribution of red fluorescence throughout the cytoplasm after ligand exposure and receptor internalization. Thus, the distinct internalization motifs behave differently with respect to arr-3 recruitment.
Residues in the Distal C-terminal Tail Promote Arrestin-3-mediated Internalization-In contrast to the central ⌬342-372 deletion, deletion of the distal C-terminal 13 residues in ⌬369 completely abolished internalization. Therefore we set out to characterize the distal C-terminal sequence 373 DSFTEATNV 381 in more detail, as this sequence appears to be a typical internalization motif containing numerous Ser/Thr and Asp/Glu residues. Consequently, all Ser/Thr or Asp/Glu residues were mutated simultaneously to Ala (ST2* and D373A,E377A, referred to as DE2*). All generated hY 2 R variants within this section as well as all variants used at later stages in this study displayed EC 50 values comparable with wild type as revealed by inositol phosphate formation in signal transduction assays (Table 2) . After co-transfection of the EYFP-fused ST2* or DE2* with arr-3-Cherry in HEK293 cells, neither internalization nor arr-3-Cherry translocation was observed (Fig. 5A) . Thus, both mutations prevented arr-3 recruitment. Next, we characterized the Ser/Thr cluster ST2 by generating a series of individual point mutants. First, combinations of double Ala mutations were generated: S374A,T376A; S374A,T379A, and T376A,T379A, all of which completely prevented agonist-induced internalization (data not shown). Next, we introduced single point mutations:
S374A, T376A, and T379A. Interestingly, agonist treatment of S374A and T379A led to a fast internalization, whereas T376A did not internalize at all (Fig. 5B, upper panel) . However, no arr-3-Cherry recruitment could be observed for S374A and T379A (Fig. 5C) . By mutating each Ser or Thr residue in ST2 individually to Asp (referred to as S374D, T376D, and T379D), we observed fast internalization for mutants S374D and T379D, whereas T376D did not internalize (Fig.  5B, lower panel) . In contrast to S374A and T379A, a weak clustering of arr-3-Cherry at the cell membrane was observed for S374D and T379D (indicated by the white boxes in Fig. 5C ; see supplemental Fig. S3 ) after ligand stimulation. When phosphorylation-independent arr-3(3A)-Cherry and S374A or T379A were co-transfected in HEK293 cells, agonist treatment led to a rapid redistribution of arr-3(3A)-Cherry to the plasma membrane, as indicated by the red punctual fluorescence pattern, similar to that obtained with wild type receptor ( Fig. 5D; see supplemental Fig. S3) . Thus, the distal sequence motif 373 DSXTEXT 379 triggers arr-3-mediated internalization. Residues in the Proximal C-terminal Tail Promote Arrestin-3-independent Internalization-As ⌬357 internalizes (in contrast to ⌬342), we studied the 343-356 segment in more detail. 347 DAIHSEVSVT 356 contains many features of typical internalization motifs, such as numerous Ser/Thr and Asp/ Glu residues. First, either Ser/Thr or Asp/Glu residues within this sequence were simultaneously mutated in the wild type receptor to Ala (ST1* and D347A,E352A, referred to as DE1*, Fig. 6A ). ST1* or DE1* C-terminal fused to EYFP were cotransfected with arr-3-Cherry in HEK293 cells. Internalization and arr-3-Cherry translocation, visualized by fluorescence microscopy, revealed behavior indistinguishable from wild type (Fig. 6, B and C, upper and middle row) . Next, the same mutations were introduced into ⌬357 (referred to as ⌬357_DE1* and ⌬357_ST1*, Fig. 6A ). Mutations D347A,E352A did not affect internalization as ⌬357_DE1* was internalized in response to agonist stimulation, with a rate comparable with ⌬357. Like ⌬357, ⌬357_DE1* was internalized in an arr-3-independent fashion (Fig. 6C, lower row) . Interestingly, for ⌬357_ST1* no agonist-induced internalization could be observed, suggesting Ser/Thr residues play an important role (Fig. 6B) . These data indicate that the Ser/Thr residues, 351 SXXSXT 356 , in the proximal C-terminal motif are important for internalization, which is arr-3-independent.
The Distal C-terminal Tail Promotes GRK2-dependent hY 2 R/Arrestin-3 Interaction-To further clarify if arr-3 recruitment and subsequent hY 2 R internalization depends on GRK2 activity, BRET assays with wild type and several mutant hY 2 R constructs in the absence or presence of overexpressed GRK2 were performed in COS-7 cells (Fig. 7) . BRET max values were not affected by cellular GRK2 levels for all receptor variants (see supplemental Table S1 ). However, GRK2 overexpression increased the apparent affinity for Venus-arr-3 for wild type hY 2 R ϳ10-fold (EC 50 ϭ 0.1195 Ϯ 0.0487 (ϪGRK2); 0.0231 Ϯ 0.0087 (ϩGRK2)). Next we compared the internalization patterns of different hY 2 R mutants with their ability to recruit arr-3 in a GRK2-dependent manner. For ⌬369 and ST2*, receptor variants that do not internalize, no receptor/ arr-3 interaction was observed as evidenced by the very low BRET max values. For receptor variants that internalize and recruit arr-3 rapidly, ⌬342-356 and ST1*, an enhanced interaction was detected along with considerably increased BRET max values compared with wild type ((ϩ)GRK2: ⌬342-356, BRET max ϭ 0.1854 Ϯ 0.0111; ST1*, BRET max ϭ 0.1019 Ϯ 0.0020; wild type, BRET max ϭ 0.0589 Ϯ 0.0075). A high apparent affinity for ⌬342-356 in concert with a high BRET max is in agreement with the substantially faster internalization kinetics compared with wild type (Fig. 2C) . These data are consistent with internalization and arr-3 recruitment properties as determined by fluorescence microscopy ( Fig. 2 and  4 -6) . ⌬357, which internalizes independently of arr-3, showed greatly reduced apparent affinity for arr-3 ((ϪGRK2) EC 50 ϭ 0.0944 Ϯ 0.0187; (ϩGRK2) EC 50 ϭ 0.2002 Ϯ 0.0573) as compared with wild type. The BRET max values (0.0588 Ϯ 0.016 (ϩGRK2)) similar to those observed for wild type, in contrast to undetectable arr-3-mCherry recruitment, are most likely due to much higher cellular concentrations of arr-3 in BRET experiments. Overall, BRET data clearly show that the wild type hY 2 R/arr-3 interaction is facilitated by GRK2. Most likely Ser and Thr residues upstream of residue 369 within the distal C-terminal tail are phosphorylated by GRK2 and participate in arr-3 recruitment. 
hY 2 R Recycling Is Regulated by Its Proximal C-terminal
Domain-All hY 2 R variants that have been shown to internalize were next studied with respect to their recycling properties in HEK293 cells. After a 60-min ligand stimulation, the respective receptor-EYFP fusion proteins were observed exclusively in endocytic vesicles (Fig. 8, 10 Ϫ6 M pNPY). Upon removal of the agonist, internalized wild type receptors recycled back to the plasma membrane after 30 min (Fig. 8,  left panel) . Recycling was not detected for variants ⌬342-356 and ⌬342-372. As a matter of interest, ⌬357 recycled comparably to wild type, suggesting that the sequence 343 EQRLDAIHSEVSVT 356 acts as a structural determinant for rapid recycling. Therefore ST1* and DE1* were investigated and revealed a moderate (ST1*) or no (DE1*) recycling for up to 120 min. However, ⌬357_DE1* displayed recycling properties comparable with wild type and ⌬357 rather than to DE1*. These results strongly indicate that the proximal Cterminal motif 343 EQRLDAIHSEVSVT 356 is not only involved in regulation of internalization, but also dictates whether receptors internalized in an arr-3-dependent manner recycle back to the plasma membrane or are degraded. Unexpectedly, we found that all hY 2 R mutants that internalize independently of arr-3 rapidly recycle. This result suggests that arrestin dissociation from hY 2 R is the rate-limiting step in the recycling of receptors internalized via a arrestin-dependent mechanism, as was previously proposed for the ␤ 2 -adrenergic receptor (38) . Additionally recycling of wild type, ⌬357, and ⌬342-372 was investigated in SMS-KAN and MHH-NB-11 cells to assure that recycling properties are not cell type dependent. Importantly, recycling properties of all studied receptor mutants in these cells were comparable with HEK293 cells (supplemental Fig. S2 ), demonstrating that changes in the receptor C terminus, rather than cell type, define the recycling pattern.
DISCUSSION
Here we analyzed the role of the hY 2 R C terminus in receptor internalization and recycling. We identified key reg- (Fig. 1, A and  B) . Therefore, we explored the mechanisms of regulation of hY 2 R internalization and subsequent recycling. A regulatory mechanism shared by many GPCRs involves receptor phosphorylation by GRKs, followed by arrestin binding and arrestin-mediated internalization via coated pits (44) . Indeed, we observed rapid arr-3 recruitment to the plasma membrane upon hY 2 R stimulation in all cell lines tested (Fig.  1D) . Consistent with the data obtained by fluorescence microscopy, quantification of receptor internalization in the presence or absence of arr-3 overexpression by cell surface ELISA, as well as analysis of hY 2 R/arr-3 interaction by BRET strongly suggested an arr-3-dependent internalization process. These data represent the first direct demonstration of hY 2 R interaction with arr-3 and are in good agreement with BRET2 studies showing slow association rates of the rhesus Y 2 R with arr-3 in HEK293 cells (39) .
Extensive effort has been invested into the identification of specific receptor motifs participating in GPCR endocytosis. The contribution of intracellular elements to internalization is well described for several GPCRs. In addition to the third intracellular loop these studies revealed a major role of the C terminus in internalization, particularly for the human neuropeptide Y 1 receptor (45), angiotensin II type one receptor (46) , human P2Y 1 receptor (47), A 2B adenosine receptor (48), TRHR (49) , and the N-formyl peptide receptor (50) . However, so far nothing is known about receptor domains involved in hY 2 R internalization. Our previous studies with hY 5 /hY 2 chimeric receptors showed that the hY 2 R C terminus plays a key role in the internalization of these receptors, because its exchange between hY 2 R and hY 5 R led to a rapid internalization of the usually non-internalizing hY 5 R (21). In all cellular systems used we identified two internalization motifs: a distal DSXTEXT ( 373 DSFTEAT 379 ) and proximal DXXXSEXSXT ( 347 DAIHSEVSVT 356 ). Interestingly, these two motifs mediate distinct internalization pathways. In contrast to wild type receptor where both motifs are intact, ⌬357, with only the proximal motif, internalizes slower and is notably defective in agonist-induced arr-3 binding. This is reminiscent of the A 2B adenosine recep- tor, where deletion of seven C-terminal amino acids eliminating several Ser/Thr residues prevented arrestin recruitment (48) . The loss of the distal C-terminal motif STXSXS of the receptor, which is homologous to the distal hY 2 R motif SX-TXXT, switched the internalization from an arrestin-dependent to an -independent mechanism (48). In general, motifs mediating arrestin-dependent internalization include clusters of Ser/Thr residues usually targeted by GRKs (51) . The direct connection of phosphorylation with internalization has been documented for angiotensin type II AT 1A (52), ␤ 2 -adrenergic receptor (53, 54) , follitropin receptor (55), somatostatin sst 2A (56) , and CRTH2 receptor (57) . Usually GPCR phosphorylation by GRKs facilitates arrestin recruitment, which connects the receptor to the endocytic machinery (51) . The presence of acidic amino acids in close proximity to these clusters can guide GRKs to the phosphorylation sites (57) (58) (59) . The distal C-terminal internalization motif 373 DSFTEAT 379 in the hY 2 R is a typical example, containing multiple Ser/Thr flanked by Asp and Glu residues. The substitution of either all Ser/Thr or Asp/Glu residues by Ala (ST2*, DE2*) in the distal hY 2 R internalization motif blocks its function, completely preventing internalization (Fig. 5A) . Here Thr 376 appears to be particularly important, because no substitution was tolerated. Notably, only a weak arr-3 clustering was observed for S374D and T379D (Fig. 5C) . Apparently, Asp acts as partial phosphomimetic (61), mimicking phosphorylated Ser/Thr residues involved in binding of the arr-3 recognition domain that has multiple positive charges (44) . The recruitment of only phosphorylation independent arr-3 obtained for S374A and T379A strongly indicates that Ser 374 and Thr 379 are potential phosphorylation sites. Thus, phosphorylation of the distal C-terminal residues Ser 374 and Thr 379 is likely required for a high affinity interaction with wild type arr-3.
We also identified a second internalization motif. This proximal sequence 347 DAIHSEVSVT 356 was found to be unique for Y 1 R and Y 2 R subtypes within the YR family. This conserved C-terminal motif (-H-(S/T)-(E/D)-V-(S/T)-X-T) was implicated in Y 1 R internalization (41, 45) . Our data provide the first evidence that this motif participates in internalization of the hY 2 R as well. The most striking finding is the mutant ⌬357 internalized, in contrast to wild type, in an arr-3-independent manner. To further characterize ⌬357 and the proximal motif associated with its internalization, we analyzed ⌬357_DE1* and ⌬357_ST1* mutants and obtained different internalization phenotypes. ⌬357_DE1* retained internalization capability, whereas ⌬357_ST1* lost the ability to internalize. Thus, in addition to Ser/Thr residues in the distal C-terminal motif, Ser/Thr residues within 347 DAIH-SEVSVT 356 seem to be crucial for internalization. The distal arr-3-sensitive motif is likely the major phosphorylation site. In contrast, the proximal internalization motif appears to be phosphorylation-independent, as it does not confer arrestin sensitivity and does not bind phosphorylation-independent arrestins. BRET assays monitoring receptor/arr-3 interaction in a GRK2-dependent manner support hY 2 R phosphorylation in the distal internalization motif. Whereas all mutants lacking the proximal tail display a high apparent affinity for receptor/arr-3 interaction (ST1* and ⌬342-356), mutants without the distal motif (ST2* and ⌬369) show little to no arrestin-3 recruitment. Thus, the distal motif upstream of amino acid 369 is the key GRK phosphorylation site. In contrast to microscopy-based arr-3 recruitment, BRET-based assays are performed with severalfold excess of arrestin over receptor, which likely accounts for differences in arr-3 recruitment as observed for ⌬357. Nonetheless, the apparent affinity of ⌬357 for arr-3 was extremely low, as compared with wild type, which is consistent with arr-3-independent internalization. Apart from the hY 2 R several other activated receptors were reported to internalize effectively in an phosphorylation-independent fashion: ␦-opioid receptors (62), leukotriene B4 receptors (63) , and substance P receptor (64) .
Because ⌬369 does not internalize, and even ⌬369_5Q does not bind arr-3, we hypothesized that the basic amino acid stretch 357 FKAKKNLEVRKN 368 located between the internal- ization motifs is an inhibitory element. Our data suggest that the distal motif is required to reverse the inhibition and allow arr-3 binding. Based on our data, we propose the following mechanism of hY 2 R internalization. First, receptor activation results in a conformational change and allows phosphorylation of the distal C-terminal motif by GRKs, which mediates the binding of arr-3, which connects the receptor with the internalization machinery of the cell. The inhibitory element, located just N-terminal to the distal motif, precludes arrestin interaction in the absence of phosphorylation and thereby prevents constitutive internalization. Phosphorylation of the distal motif functionally neutralizes the inhibitory segment, allowing arrestin binding to wild type receptor. When the distal motif is absent, the inhibitory element blocks the proximal motif and therefore completely prevents internalization (e.g. ⌬369). If both the distal motif and the inhibitory sequence are eliminated, the receptor (e.g. ⌬357) internalizes in an arr-3-independent manner (Fig. 9) .
It is worth noting that multiple internalization mechanisms were proposed for the related Y 1 R subtype. Arr-3-dependent internalization was shown to be predominant, but arrestin-independent mechanisms have been implicated in the control of internalization (45) . Muscarinic M2 receptor was also shown to bind arrestins, but internalize via an arrestin-independent pathway (65, 66) . Interestingly, M2 (65, 66) and opioid (67) receptors also have inhibitory elements that act as "brakes" of internalization. In both cases the inhibition is normally relieved by the phosphorylation of these elements, but it can be artificially eliminated by their deletion.
Once the receptors have been internalized, they can either be targeted to recycling endosomes and traffic back to the cell surface or translocate to lysosomes for degradation (68, 69) . Receptor down-regulation is related to the binding affinities of GPCRs for arrestins. GPCRs were classified into two groups. Class A receptors have a higher affinity for arr-3 and form transient GPCR-arrestin complexes, which dissociate near the cell surface (e.g. ␤ 2 -adrenergic, -opioid, and dopamine D1A receptors). Class B receptors have equal affinities for arr-2 and arr-3, and the GPCR-arrestin complex is stable and remains intact during the internalization process (e.g. vasopressin V2, neurotensin 1, and angiotensin II type 1A receptors) (68, 70 -72) . Decreased or increased affinity of the mutant arrestin complex with the same ␤ 2 -adrenergic receptor was shown to direct it to recycling or the degradation pathway, respectively (38, 73) . We found that after ligand exposure, the redistributed arr-3 is confined to the cell periphery and does not traffic along with the activated hY 2 R to endocytic vesicles, suggesting that the hY 2 R belongs to class A. Class A GPCRs are known to be recycled rather than de- . Proposed mechanism underlying hY 2 R internalization. The hY 2 R C terminus consists of three regulatory sequence motifs: a proximal internalization motif (light gray bar), an inhibitory sequence (white bar with a black line), and a distal internalization motif (dark gray bar). Agonist stimulation induces a conformational change within the receptor, and depending on the exposure of distinct motifs multiple mechanisms operate: a) the distal motif is exposed to the cytoplasm to get phosphorylated, which then enables arr-3 binding and subsequent internalization (wild type receptor). b) When the receptor lacks the distal motif the inhibitory element blocks the proximal internalization motif, precluding internalization (⌬369). c) When the receptor lacks both the distal motif and the inhibitory sequence, the proximal internalization motif is accessible and acts as backup motif to promote phosphorylation-and arr-3-independent internalization (⌬357).
graded. Indeed, the identified sequence within the proximal C-terminal tail is responsible for fast hY 2 R recycling in different cellular environments ( Fig. 8 and supplemental Fig. S2 ). Our data indicate that early dissociation of hY 2 R/arr-3 complex at the plasma membrane is a prerequisite for rapid recycling, because the dissociation of arrestins from the receptor makes it accessible for phosphatases in early endosomes and consequently allows receptor recycling (74) . Interestingly, the recycling motif in hY 2 R overlaps with the conserved motif (-H-(S/T)-(E/D)-V-(S/T)-X-T), which also contributes to arr-3-independent internalization.
Furthermore, only the variants that carry the functional motif are able to recycle as fast as wild type receptor. Mutations within this motif resulted in a dramatically reduced recycling capability or even completely prevented recycling. However, with respect to specific recycling motifs there is only little information available. All of the identified C-terminal motifs differ in length and sequence from each other and from the identified hY 2 R motif: ␤ 1 -adrenergic (ESKV) and ␤ 2 -adrenergic receptor (DSLL), -opioid (LENLEAE), and -opioid receptors (NKPV), thyrotropin stimulating hormone receptor (TVL), and CRTH2 receptor (DSEL) (57, 75 ). It appears that in addition to the sequence itself, the nature of the surrounding residues, as well as sterical and conformational requirements play a major role in receptor recycling.
In summary, the removal of ligand-activated GPCRs from the cell surface by internalization and subsequent down-regulation or recycling contributes to the tight regulation of GPCR responsiveness. Understanding this complex mechanism is particularly important for pharmaceutical targets, such as hY 2 R. Different therapeutic interventions are conceivable at the level of receptor internalization. Because multiple peptide hormone receptors are known to be overexpressed in several human cancer cells, ligand-induced internalization could serve as a means of anti-tumor therapy and diagnosis (76) . The drug often needs to be shuttled into tumor cells, and ligand-induced receptor internalization could be used as a delivery route. Effective receptor internalization allowed the use of agonists as functional antagonists of the S1P 1 receptor (5). A third therapeutic approach utilizing internalization was described for the prevention of HIV-1 infection: the administration of receptor-selective ligands leading to the removal of co-receptors (like CCR5 and/or CXCR4) from the cell surface reduces the probability of HIV-1 infection (60). Thus, the molecular mechanisms of GPCR internalization could be exploited in many ways for therapeutic purposes.
In conclusion, we demonstrated that hY 2 R recruits arr-3 to the plasma membrane. Moreover, we characterized two independent C-terminal internalization motifs in the hY 2 R: proximal and distal motifs that trigger arr-3-independent and -dependent internalization. We also showed for the first time that the hY 2 R C terminus contributes to receptor recycling, and identified an inhibitory sequence located in the central C-terminal tail. Thus, the hY 2 R is subject to a highly sophisticated trafficking regulation, which involves multiple molecular events. Our findings identified distinct structural determinants playing crucial roles in internalization and recycling processes.
